Skip to content

EEG@HOME (Phase 4 of the Project)

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02394639
Enrollment
0
Registered
2015-03-20
Start date
2015-04-30
Completion date
2016-09-30
Last updated
2017-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Brief summary

The goal of this project is the development of an EEG-cap (min. 21 electrodes) with user-friendly active dry electrodes that meets the expectations of the users regarding comfort and esthetics, without losing sight of the functional and technical demands for recording high quality EEG signals. The purpose is to use the EEG-cap to investigate clinical neurological disorders (e.g. epilepsy). The EEG-cap could also be used at home so that hospital admission in the EMU can be avoided for some patients and an increasing number of patients can be examined. In this stage of the project video-EEG recording with the prototype will be compared to the conventional way (cup-electrodes and collodion) of recording in the EMU. Minimum 1 - maximum 10 patients with prominent IEDs will be included. After the conventional recording is completed, the patient will undergo a recording of maximum 5 hours with the prototype. There will be an visual and clinical evaluation of the EEG-signals (blinded) and a technical evaluation of the EEG-signals. User experience and experience of the EEG-technologists will also be collected.

Interventions

Sponsors

Universitaire Ziekenhuizen KU Leuven
CollaboratorOTHER
Pilipili NV
CollaboratorINDUSTRY
Imec
CollaboratorINDUSTRY
University Hospital, Ghent
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
4 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Epilepsy with on EEG prominent IEDs

Exclusion criteria

* /

Design outcomes

Primary

MeasureTime frame
EEG signal quality (visual and clinical) (scale)5 hours
EEG signal quality (technical) (signal to noise ratio)5 hours
User experience (questionnaire)5 hours

Secondary

MeasureTime frame
EEG-technologist experience (questionnaire)5 hours

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026